Adjuvant capable of specifically activating the adaptive...

Details Adjuvant capable of specifically activating the adaptive... Adjuvant capable of specifically activating the adaptive...

2004-04-02

2011-12-13

Chen, Stacy B. (Department: 1648)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

C424S278100

Reexamination Certificate

active

08076059

ABSTRACT:
A composition for eliciting an immune response to an immunogen comprises an immunogen in combination with a mast cell membrane activator such as compound 48/80. Any suitable immunogen may be employed, such as an antibody-inducing determinant, a lipid, a peptide (e.g., an antibody-inducing peptide), a carbohydrate, an immunogen derived from a virus or cancer cell, etc. Methods of use are also described.

REFERENCES:
patent: 4652629 (1987-03-01), Patrick et al.
patent: 4834976 (1989-05-01), Rosok et al.
patent: 5626844 (1997-05-01), Lemley et al.
patent: 6270758 (2001-08-01), Staats et al.
patent: 6271202 (2001-08-01), Kudsk
patent: 6375944 (2002-04-01), Trinchieri et al.
patent: 6413935 (2002-07-01), Sette et al.
patent: 7105171 (2006-09-01), Stephens et al.
patent: 2002/0058293 (2002-05-01), Takesako et al.
patent: 2005/0063978 (2005-03-01), Fritz et al.
patent: WO02/32451 (2002-04-01), None
Mielcarek et al. Interaction ofBordetella pertussiswith mast cells, modulation of cytokine secretion by pertussis toxin. Cellular Microbiology, Mar. 2001, vol. 3, No. 3, 181-188.
Lenney et al. Antimicrobial action of Compound 48/80 against protozoa, bacteria and fungi. Journal of Pharmaceutical Sciences. May 1997, vol. 66, No. 5, 702-705.
Hood et al. Immunology, 2nd Edition. The Benjamin/Cummings Publishing Company, Inc., California, 1984, 371-373.
Lenney et al. Antimicrobial Action of Compound 48/80 against protozoa, bacteria and fungi. Journal of Pharmaceutical Sciences, May 1977, vol. 66, No. 5, 702-705.
Lenney et al. “Antimicrobial Action of Compound 48/80 against Protozoa, Bacteria and Fungi.”Journal of Pharmaceutical Sciences, 1997. vol. 66, No. 5, pp. 702-705.
Malaviya et al. “Mast Cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha.”Nature, 1996. vol. 381, pp. 77-80.
PCT International Search Report for International Application No. PCT/US04/10429, Mailed Aug. 12, 2005 (2 pages).
SIGMA. Compound 48/80, Sigma product No. C2313, Dec. 15, 1997, Saint Louis. (2 pages).
Fritz et al. (2004) “The Artificial Antimicrobial Peptide KLKLLLLLKLK Induces Predominantly a TH2-type immune response to co-injected antigens.” Vaccine 22, pp. 3274-3284.
Dorland's Illustrated Medical Dictionary, 25th Ed. (1974), pp. 764-765. W.B. Saunders, Philadelphia.
Specific Immunity: Active and passive immunity. University of Auckland Immunisation Advisory Centre (IMAC) NZ. (2008), 2 pp, printed Sep. 2, 2008.

Affiliated with

Also associated with

Rating

Adjuvant capable of specifically activating the adaptive... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Adjuvant capable of specifically activating the adaptive..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adjuvant capable of specifically activating the adaptive... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4311969